Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Sarcoma 2Myeloid 1Lymphoid 1Head & Neck 1Dermatologic 1CNS 1Breast 1

Conditions

Breast Neoplasms 341Neoplasms 247Prostatic Neoplasms 196Colorectal Neoplasms 147Lung Neoplasms 133Carcinoma, Non-Small-Cell Lung 113Leukemia, Myeloid, Acute 108Pancreatic Neoplasms 99Multiple Myeloma 90Precursor Cell Lymphoblastic Leukemia-Lymphoma 77Brain Neoplasms 74Glioblastoma 70Head and Neck Neoplasms 69Carcinoma, Hepatocellular 67Squamous Cell Carcinoma of Head and Neck 62Melanoma 60Neoplasm Metastasis 56Uterine Cervical Neoplasms 55Ovarian Neoplasms 54Rectal Neoplasms 51Stomach Neoplasms 49Hematologic Neoplasms 48Myelodysplastic Syndromes 45Carcinoma, Renal Cell 45Recurrence 43Motor Activity 43Glioma 43Triple Negative Breast Neoplasms 42Esophageal Neoplasms 40Lymphoma, Non-Hodgkin 39

Interventions

testosterone 17 beta-cypionate 1temsirolimus 1Valproic Acid 1Testosterone Propionate 1Standard of Care 1Sirolimus 1Practice Guidelines as Topic 1Methyltestosterone 1Immunoglobulin G 1Gemcitabine 1Disulfides 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Urologic Neoplasms × 30 days × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

NCT03093909 2026-05-20

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

M.D. Anderson Cancer Center

Phase 1 Recruiting
44 enrolled
DermatologicGenitourinarySarcoma

Bone Neoplasms, Melanoma, Osteosarcoma, Urologic Neoplasms

NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡